Lee Ainslie - Maverick Capital
Holding/activity history for Nektar Therapeutics (NKTR)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2022 Q3 | 0 | 0 | Sell 100.00% | 0.31 | |
| 2022 Q2 | 3,218,382 | 0.31 | Reduce 32.85% | 0.15 | $3.80 |
| 2022 Q1 | 4,792,920 | 0.46 | Reduce 17.68% | 0.10 | $5.39 |
| 2021 Q4 | 5,822,604 | 0.95 | Reduce 0.27% | 0.00 | $13.51 |
| 2021 Q3 | 5,838,426 | 1.16 | Add 1.34% | 0.02 | $17.96 |
| 2021 Q2 | 5,761,073 | 0.93 | Reduce 1.66% | 0.02 | $17.16 |
| 2021 Q1 | 5,858,316 | 1.10 | Reduce 11.98% | 0.15 | $20.00 |
| 2020 Q4 | 6,655,625 | 1.81 | Add 17.21% | 0.27 | $17.00 |
| 2020 Q3 | 5,678,221 | 1.75 | Add 9.48% | 0.15 | $16.59 |
| 2020 Q2 | 5,186,637 | 2.53 | Add 5.88% | 0.14 | $23.16 |
| 2020 Q1 | 4,898,401 | 1.84 | Add 51.13% | 0.62 | $17.85 |
| 2019 Q4 | 3,241,234 | 1.02 | Buy | 1.02 | $21.58 |